Download this PDF file

6 downloads 36 Views 1MB Size Report
statistics to make sure they tally and match data cited in the text. Do not submit tables ... Provide the printout of the manuscript that exactly matches the disk file. File names must be .... A floppy diskette or CD containing the manuscript, tables and figures. ▫ Abstract size is ..... mass, thus recovery of ovulation may occur after a.
Iranian Journal of

Reproductive Medicine VOLUME 9

SUPPLEMENT 1

WINTER 2011

ISSN: 1680-6433

ABSTRACT BOOK Published by: Yazd Research & Clinical Center for Infertility. In collaboration with: Iranian Society for Reproductive Medicine.

CHAIRMAN MANAGER Vahidi, Serajedin M.D. EDITOR-IN-CHIEF Aflatoonian, Abbas M.D. MANAGING EDITOR Anvari, Morteza Ph.D. EXCUTIVE BOARD Abdoli, Ali Mohammad M.D. Asadzadeh, Kobra B.S. Khani, Parisa M.D. Mortazavifar, Zahra Sadat B.S. Sheikhha, Mohammad Hasan M.D., Ph.D. EDITORIAL BOARD Ahmadi, Ali Ph.D. (USA) Al-Hassani, Safa Ph.D. (GERMANY) Hosseini, Ahmad Ph.D. (IRAN) Hosseini, Seyed Jalil M.D. (IRAN) Kalantar, Seyed Mehdi Ph.D. (IRAN) Karimzadeh Meybodi, Mohammad Ali M.D. (IRAN) Kazemeyni, Seyed Mohammad M.D. (IRAN) Khalili, Mohammad Ali Ph.D. (IRAN) Lenton, Elizabeth Ann Ph.D. (UNITED KINGDOM) Monsees, Thomas Ph.D. (GERMANY) Moini, Ashraf M.D. (IRAN) Nasr-Esfahani, Mohammad Hossein Ph.D. (IRAN) Pour-Reza, Maryam M.D. (IRAN) Pourmand, Gholamreza M.D. (IRAN) Yasini, Seyed Mojtaba M.D. (IRAN) The Iranian Journal of Reproductive Medicine is indexed in Institute for Scientific Information (ISI), Scopus, Chemical Abstract Services, CAB Abstract, Index Copernicus, Index Medicus for the WHO Eastern Mediterranean Region (IMEMR), Directory of Open Access Journals (DOAJ), EBSCO, Socolar, SCI, Magiran, Scientific Information Database (SID), Iran Medex, Open J-Gate, Bioline International and approved by Medical Journals Commission of the Ministry of Health and Medical Education. Publication Permission No.13372 IJRM Office, Research & Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. P.O. Box: 89195-999 Yazd, Iran Tel/fax: +98 (351) 8248348 E-mail: [email protected] Website: www.ijrm.ir

Instructions to Authors Aims and Scope The Iranian Journal of Reproductive Medicine (IJRM) is an international scientific quarterly publication of the Research and Clinical Center for Infertility of Shahid Sadoughi University of Medical Sciences and Health Services. Publication of IJRM benefits from copyright protection in accordance with Universal Copyright Convention. All published articles will become the property of the IJRM. The editor and publisher accept no responsibility for the statements expressed by the authors here in. Also they do not guarantee, warrant or endorse any product or service advertised in the journal. This journal accepts Original Papers, Review Articles, Short Communications, Case Reports and Letters to the Editor in the fields of fertility and infertility, ethical and social issues of assisted reproductive technologies, cellular and molecular biology of reproduction, including the development of gametes and early embryos, assisted reproductive technologies in model system and in a clinical environment, reproductive endocrinology, andrology, epidemiology, pathology, genetics, oncology, surgery, psychology and physiology. Emerging topics including cloning and stem cells are encouraged.

Submission of manuscript All authors must sign the “submission form” agreement before the article can be processed. This transfer agreement enables IJRM to protect the copyright material for the authors. The copyright transfer covers the exclusive rights to reproduce and distribute the article, including reprints, photographic reproductions, microform or any other reproductions of similar nature and translations, and includes the right to adapt the article for use in conjunction with computer system and programs, including reproduction or publication in machine-readable form and incorporation in retrieval systems. Authors are responsible for obtaining from the copyright holder permission to reproduce all figures for which copyright exists. Always submit three photocopies of the entire manuscript and a diskette that contains the manuscript and had been created by Microsoft Word, along with three sets of photographs, illustration, diagrams etc to mentioned address. A covering letter identifying the person (full name, address, telephone, fax numbers and e-mail) responsible for correspondence concerning the submitted article should accompany all manuscripts. Manuscripts are received with the understanding that they are not under simultaneous consideration by another publication. The author’s transmittal letter must accompany the manuscript and contain these statements: “The manuscript has been seen and approved by all authors involved and is neither being published nor being considered for publication elsewhere. The authors transfer copyright to the IJRM.” In case of electronic submission of the manuscript the authors must declare that it is being exclusively contributed to IJRM. The text should be submitted in Microsoft Word format as an attachment. The figures should be sent in a format of JPEG or GIF which will produce high quality images in the online edition of the journal. Submission is also acceptable via Journal URL: http://www.ijrm.ir

Guidelines for preparation of manuscript Manuscript length Papers should be of a length appropriate for the amount of information they contain. Failure to restrict the length of manuscripts can negatively influence the editor’s decisions. Style Manuscripts should be written using clear and concise English. The manuscript should include: Title page; the Abstract; Introduction; Materials and Methods; Results; Discussion; Acknowledgement and References. Manuscript format The format of the IJRM manuscripts, including tables, references, and figure legends must be type written, double-spaced, on one side of A4 paper, with margins of 2.5 cm. Pages should be numbered consecutively, beginning with the title page and continuing through the last page of typewritten material. Avoid underlining.

II

 Original articles should have the following format: Title page The title page must contain (1) title of article, (2) correct names and highest academic degree of each author, (3) each author’s official academic and/or clinical title and affiliation, (4) name and address of the institution(s), (5) name, address, telephone number, e-mail and fax number of author to whom correspondence should be sent. Running title The author should provide a running title of no more than 50 characters. Abstract All original articles must contain a structured abstract of not more than 250 words. The abstract should include; Background, Objective, Materials and Methods, Results, Conclusions and at least 3 to 5 Key words, chosen from the Medical Subject Headings (MeSH) list of index medicus (http://www.nlm.nih.gov/mesh/MBrowser.html). They should therefore be specific and relevant to the paper. Authors need to be careful that the abstract reflects the content of the article accurately. For Randomized Controlled Trials the method of randomization and primary outcome measure should be stated in the Abstract. Introduction This should summarize the purpose and the rationale for the study. It should neither review the subject extensively nor should it have data or conclusions of the study. Materials and Methods This should include the study design and exact method or observation or experiment, definitions such as for diagnostic criteria, the population or patient samples, and laboratory and statistical methods. If an apparatus is used, its manufacturer’s name and address should be given in parenthesis. If the method is established, give reference but if the method is new, give enough information so that another author is able to perform it. Statistical method must be mentioned and specify any general computer programme used. Results This should include the pertinent findings in a logical sequence with tables and figures as necessary. It must be presented in the form of text, tables and illustrations. The contents of the tables should not be all repeated in the text. Instead, a reference to the table number may be given. Long articles may need sub-headings within some sections (especially the Results and Discussion parts) to clarify their contents. Unnecessary overlap between tables, figures and text should be avoided. Discussion The discussion should emphasize the present findings and the variations or similarities with other work done in the field by other workers. Conclusions based on the findings, evidence from the literature that supports the conclusions, applicability of the conclusions, and implications for future research. The detailed data should not be repeated in the discussion again. Emphasize the new and important aspects of the study and the conclusions that follow from them. It must be mentioned whether the hypothesis mentioned in the article is true, false or no conclusions can be derived. Acknowledgements All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. Financial and material support should also be acknowledged. Personal acknowledgement should precede those of institutions or agencies References All manuscripts should be accompanied by relevant references. The Reference should provide the following information as stated in the presented models as follows:

III

1. References should be numbered sequentially as they appear in the text according to the Vancouver style. When citing authors in the text, acknowledge only the first author where there are three or more authors, e.g. Williams et al (1) stated that.... Where there are two authors cite both, e.g. Jones and Smith (2) reported that.... Citations in the reference list are to be arranged by number in the following format including punctuation. Journals: Author(s). Title of article. Title of journal (in italics with no full stops) Year; Volume number: Page numbers. (Abbreviations for journals used in the reference list should conform to Index Medicus.) e.g. Salehnia M, Arianmanesh M, Beigi M. The impact of ovarian stimulation on mouse endometrium: a morphometrical study. Iran J Rep Med 2006; 4:7-11. Books: Author(s). Title: sub-title. Edition. Place of publication: Publisher; Year. e.g. Speroof L, Robert H. Clinical gynecology endocrinology & infertility .6th Ed. Philadelphia; Robert-D; 1999. Chapter in a book: Author(s) of chapter. Title: sub-title of chapter. In: Author(s) (or editors) of the book. Title: sub-title of book. Place of publication: publisher; Year; page numbers. Inclusive page numbers should be given for all references. Print surnames and initials of all authors when there are six or less. In the case of seven or more authors, the names of the first six authors followed by et al should be listed. References to papers accepted for publication, but not yet published, should be cited as such in the reference list e.g. Mohammad Kazem Gharib Naseri M, Mohammadian M, Gharib Naseri Z. Antispasmodic effect of Physalis alkekengi fruit extract on rat uterus, IJRM 2008, in press. The author is responsible for the accuracy and completeness of the references and for their correct textual citation. Tables In limited numbers should be submitted with the captions placed above.Each table should be numbered consecutively with Roman numerals and typed double-spaced, including all headings. Verify tabular statistics to make sure they tally and match data cited in the text. Do not submit tables as photograph. Figures Should be in limited numbers, with high quality art work and mounted on separate pages. The captions should be placed below. The same data should not be presented in tables, figures and text, simultaneously. Clinical Trial Registration From January 2010, all of the Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir), in order to be considered for publication. This includes all of the clinical trials performed inside Iran even if they register in other registration sites. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O. According to the International Committee of Medical journal Editors (ICMJE) a Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more healthrelated interventions to evaluate the effects on health outcomes. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.  Review articles should be prepared according to one of the following styles: − Systematic reviews should be in form of meta-analysis, meta synthesis or without statistical analysis. These articles contain original articles’ parts. − Non systematic reviews should be written by experts who have at least one published article in the related field in references. Different parts of such articles include abstract, introduction, discussion and conclusion. They should contain at least 20 references and maximum 5000 words.  Short communication can be in form of research article, systematic review or ongoing research which

reports its interesting findings. The parts in this type of articles are like those of original one but they are smaller and prepared in maximum 2000 words.

IV

 A letter to the editor should be about criticism of previous articles, criticism or review over books,

analysis of a related topic with reproductive medicine, expansion and explanation about an idea or a complicated problem. This should be prepared in maximum 1000 to 1500 words. These articles need no structure.  Editorial article should be written by either the editor in chief or the editorial board. The editor in chief

could also ask an expert to do such a thing. The context of such articles could involve a deep analysis about the up to date topics in reproductive medicine, challenging systems or proposing solutions in reproductive medicine field. They should be prepared in maximum 2000 words and have at least 5 references.  Case Reports and Brief Reports: Both should include abstract, keywords, case presentation, discussion,

acknowledgment, references, and 1 – 4 figures. Necessary documentations of the case(s) like pathology reports, laboratory test reports, and imaging should be included in the submission package. Brief reports should not have more than one figure and/or table.

Illustrations Three copies of all figures or photographs should be included with the submitted manuscript. Photographs must be high-contrast, glossy, black and white prints, unmounted and untrimmed, with preferred size of 10 x 15 cm. Color transparencies or photos will be accepted at the discretion of Editorial Board. Figure number, and name of senior author, should be written on the back of each illustration. Written permission must accompany any photograph in which the subject can be identified or any illustration that has been previously published. All illustrations must be numbered as cited in the text in consecutive numeric order.

Submission requirements

 Submit only the final version of the manuscript.  The file should be in Microsoft Word.  Provide the printout of the manuscript that exactly matches the disk file. File names must be clearly indicating the contents of each file.  Prepare art as camera-ready copy. Laser prints are accepted. Page charges: There is no page charge for publication in the IJRM. Reprint: Ten reprints will be provided free of charge. The corresponding author will be supplied with 3 free issues.

Ethics of studies involving humans and animals Ethical considerations must be addressed in the Materials and Methods section. 1) Please state that informed consent was obtained from all participants. 2) Include the name of the appropriate institutional review board that approved the project. 3) Indicate in the text that the maintenance and care of experimental animals complies with National Institutes of Health guidelines for the humane use of laboratory animals, or those of your Institute.

Statistics Inadequate or incorrect statistical analyses frequently cause rejection or delays in the review of manuscripts. Where appropriate, authors should seek advice from a professional statistician before the manuscript is submitted.

Ethics of scientific publishing Submission of a paper implies that it reports unpublished work and that it is not under consideration for publication elsewhere. If previously published tables, illustrations or text are to be included, then this should be clearly indicated in the manuscript and the copyright holder's permission must be obtained. Previously published material can be cited in a later review or commentary article, but it must be indicated using quotation marks if necessary.

V

Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged. Fraudulent data or data stolen from other authors is also unethical and will be treated accordingly. Any alleged offence is considered initially by the Editorial Team.

Conflicts of interest Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in, an organization that may profit or lose through publication of your paper.

Copyright The entire contents of IJRM are protected under international copyrights. This Journal is for your personal noncommercial use. You may not modify copy, distribute, transmit, display, or publish any materials contained on the Journal without the prior written permission of it or the appropriate copyright owner.

Review process The submitted manuscripts will be assessed from editorial points of view, at first. Should the manuscript meet the basic editorial requirements; it will enter the peer-review process. The manuscript will then be sent at least to one in-office and two out of office referees for review. The corresponding author will then be informed to the referee’s remark to accept, reject or require modification. Revision: Papers may be returned to authors for modification of the scientific content and/or for language corrections. Revised paper and a letter listing point-for-point response to the reviewers must be submitted to the Editor and must be accompanied by a copy of the original version. Suggestion by the Editor about resubmission does not imply that a revised version will necessary be accepted. If a paper that is returned to the authors for modification is not resubmitted within two months it will be regarded as having been withdrawn and any revised version received subsequently will be treated as a new paper and the date of receipt will be altered accordingly. Authors who resubmit a paper that has previously been rejected must provide the original manuscript and a letter explaining in detail how the paper has been modified. Accepted manuscripts become the property of IJRM. Proofs: A computer printout will be sent to the corresponding author to be checked for only typographical errors and other essential small changes before publication in order to avoid any mistakes. Major alternations to the text cannot be accepted at this stage. Proofs must be returned to the Editor within 2 days of receipt.

Responsibilities of authors The authors are responsible for accuracy of all statements and data contained in the manuscript, accuracy of all references information, and for obtaining and submitting permission from the author and publisher of any previously published material included in the submitted manuscript. The corresponding author will receive an edited manuscript for “final author approval”.

Disposal of material Once published, all copies of the manuscript, correspondence and artwork will be held for 1 years before disposal.

Submit manuscripts to: The Editor in Chief, Iranian Journal of Reproductive Medicine, Research & Clinical Center for Infertility, Bouali Ave, Safayeh, Yazd, Iran. P.O. Box, 89195-999. Telephone: +98 (351) 8247085. Tel/Fax: +98 (351) 8248348. E-mail: [email protected] URL: http://www.ijrm.ir

VI

Iranian Journal of Reproductive Medicine Submission Form Corresponding Author: Manuscript Title: Mailing Address:

Phone: Fax: Cell Phone: E-mail: Check List (Failure to complete will delay processing of the manuscript):  One original and 3 copies of the manuscript together with three original figures and photographs are enclosed.  A floppy diskette or CD containing the manuscript, tables and figures.  Abstract size is not exceeded 250 words.  The format of manuscript conforms to the IJRM Instructions to Authors.  Entire manuscript (including references and tables) are typed double spaced with margins of at least 2.5 cm for each sides of page on one side of A4 paper.  Entire manuscript is typed in a font of at least 12 points in Times New Romans.  A legend is provided for each figure on a separate page at the end of the manuscript.  All symbols are explained in legends and all symbols in legends appear in figures.  References are numbered in the order in which they appear in text in parentheses.  References are checked for accuracy against original source and formatted according to the IJRM Instructions to Authors.  Contents of the manuscript have not been previously published and are not currently submitted elsewhere.  All human and animal studies are approved by an Institutional Review Board.  All listed authors have seen and approved of the manuscript.  I accept responsibility for the scientific integrity of the work described in this manuscript.

Please refer to the IJRM Instructions to Authors for further information. Signature:

Date:

Note: Neither manuscript nor figures will be returned after review. Mail the manuscript to: Dr. Abbas Aflatoonian, Editor in Chief Iranian Journal of Reproductive Medicine, Research & Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bouali Avenue, Safayeh, Yazd, Iran. P.O. Box: 89195-999.

VII

Assignment of copyright and authorship responsibilities Manuscripts published in the Iranian Journal of Reproductive Medicine become the sole property of, with all right in copyright reserved to, the Yazd Research & Clinical Center for Infertility. The undersigned authors hereby affirm that the manuscript entitled: ………………………………………………………………………………………………………………………………………………………… ………………………………………………………………………………………………………………………………………………………… …………………………………………………………………………………………………………………………………………………………

is original and that all the statements asserted as facts are based on the author(s) investigation and research. The manuscript has not been published in any form and is not being submitted for in the form of scientific presentations. If the above requirements are not fulfilled, justification for duplicate publication and permission to republish copyrighted materials must be declared and accompanied by a covering letter. In signing this form, the authors acknowledge that they have participated in the work in a substantive way and are prepared to take full responsibility for the data presented herein. The author(s) in the event of the acceptance of the above manuscript for publication, does hereby assign and transfer to Iranian Journal of Reproductive Medicine all of the rights and interests with respect to the above copyright either in its current or any other form including revised or electronically disseminated versions. All authors must sign: (Please mark the corresponding author) No.

Date

Name

Category (% of contribution)

Signature

1

2

3

4

5

6

7

8

I/We agree with the publication of the above manuscript in Iranian Journal of Reproductive Medicine as its main author/co-author.

Sign by Correspondence author:

VIII

Signed Date:

Abstracts of the 17th Congress of Iranian Society for Reproductive Medicine Tehran, Iran 2-4 March 2011

President: Nowroozi MR, M.D.

Scientific Secretary: Salehpur S, M.D.

Executive Secretory: Movahedin M, Ph.D. Scientific Committee Secretary: Gynecology Committee: Salehpur S, M.D. Embryology Committee: Movahedin M, Ph.D. Urology Committee: Nowroozi MR, M.D. Midwifery Committee: Khodakarami N, Ph.D.

IX

Executive Committee 1. Arman E. 2. Ebadi M. 3. Mazaheri Z.

4. Moniri ZA. 5. Saeidi E.

Scientific Committee A-Gynecology, Infertility 1. Abdollahifard S. 2. Abedi-Asl Zh. 3. Aflatoonian A. 4. Agha Hosseini M. 5. Aghsa MM. 6. Ahangari R. 7. Ahmadi SM. 8. Akbari Asbagh F. 9. Alborzi S. 10. Aleyasin A. 11. Ali Akbarian A. 12. Arefi S. 13. Asefjah H. 14. Asgharnia M. 15. Ashrafi M. 16. Ashrafi Nia M. 17. Ayatollahi H. 18. Azargon A 19. Azhar H. 20. Badakhsh MH. 21. Basirat Z. 22. Choobsaz F. 23. Dabir Ashrafi H. 24. Davar R. 25. Dehbashi S. 26. Dehghani Firooz Abadi R. 27. Esmaeilzadeh S. 28. Falahi S. 29. Farazday L. 30. Farimani M. 31. Forouhan B. 32. Forozanfar F. 33. Ghadiri M. 34. Ghafoorizadeh Yazdi M. 35. Ghafourzadeh M. 36. Ghahiri A 37. Ghalambor Dezfouli F. 38. Ghasem Zadeh A. X

39. Habib Zadeh V. 40. Hossein Rashidi B. 41. Joolaee S. 42. Kalantari A. 43. Kamkar M. 44. Kandi Bidgoli T. 45. Karimi M. 46. Karimpour A. 47. Kazerouni T. 48. Keikha F. 49. Khazai Z. 50. Ketabi M. 51. Madani T. 52. Mahrzad Sadghiyani M. 53. Mansouri Tarshizi M. 54. Mehdizadeh A. 55. Mehrafza M. 56. Moayed Mohseni S. 57. Moeini A. 58. Mogharab F. 59. Mohamad Zadeh A. 60. Mohamadiyan F. 61. Mohammadbeigi R. 62. Mojibian J. 63. Moosavi A. 64. Moosavifard N. 65. Motazedian SH. 66. Nazari T. 67. Nikhbakht.R 68. Parsanejad MA. 69. Poor Reza M. 70. Rahmani E. 71. Rasekh jahromi A. 72. Ramezanzadeh F. 73. Raoufi Z. 74. Robati M. 75. Rostami S. 76. Sadri S.

77. Safdarian L. 78. Sahand M. 79. Sahar Khiz N. 80. Saheb Kashaf H. 81. Saraf Z. 82. Saremi AT. 83. Salehpoor S. 84. Shahrokh Tehraninejad E. 85. Shahshahani Z. 86. Sharafi SA. 87. Tabatabaipur M. 88. Taheripanah R. 89. Tizro GHR. 90. Vahid Roodsari F. 91. Yavangi M. 92. Zadeh Modares SH. 93. Zafarghandi SH. 94. Zarei A. 95. Ziaei S. 96. Zolghadr J. 97. Akbarian R. 98. Modares Gilani M. 99. Hantoshzadeh S. 100. Vafai H. 101. Marsosi V. 102. Yazdani M. 103. Samiee H. 104. Mehrdad N. 105. Jafarabadi M.

106. Robati M. 107. Nasrin A. 108. Hamedi B. 109. Samsami A. 110. Amoyi S. 111. Foroghinia L. 112. Kasraian M. 113. Momtahen M. 114. Namavar Jahromi B. 115. Tavana Z. 116. Paydar M. 117. Maghomi H. 118. Khani B. 119. Chaychyan SH. 120. Kheshti F. 121. Abtahi SM. 122. Eslamian M. 123. Ghafari F. 124. Hossini MS. 125. Ayatollahi H. 126. Moini M. 127. khairandish P. 128. Astane M. 129. Eftekhar T. 130. Ghazizade SH. 131. Karimzadeh Meybodi MA. 132. Pourdast T. 133. Namavar B.

B- Embryology 1. Abed F. 2. Abolhasani F. 3. Abutorabi R. 4. Amanpour S. 5. Amjadi SH. 6. Abolhassani F. 7. Akhoondi MM. 8. Aliabadi E. 9. Amir Arjmand MH. 10. Amiri I. 11. Anvari M. 12. Baharvand H. 13. Bahmanpoor S. 14. Beiki AA. 15. Davari M. 16. Ebrahimzadeh AR. 17. Eftekhari Yazdi P. 18. Eimani H.

19. Esmaeil Nejad Moghadam A. 20. Esmaeilpor T. 21. Fathi F. 22. Ghafari M. 23. Hashemi Tabar M. 24. Hassani H. 25. Hosseini A. 26. Hossein-Jada SH. 27. Jalali M. 28. Joursaraei GhA. 29. Kabir Salmani M. 30. Karimian L. 31. Karimpoor A. 32. Kermani T. 33. Kalantar SM. 34. Khalili MA. 35. Khaki A. 36. Khazaei M.

XI

37. koshesh L. 38. Koruji M. 39. Mirshekari.T 40. Mesbah SF. 41. Moazeni M. 42. Movahedin M. 43. Nasr Esfahani MH. 44. Nematollahi N. 45. Niknafs B. 46. Nikzad H. 47. Noori M. 48. Rezazadeh M. 49. Rezai A.

50. Sadeghi MR. 51. Sadr Khanloo R. 52. Saeidi G. 53. Salehnia M. 54. Salsabili N. 55. Shafeei M. 56. Shahverdi AH. 57. Sobhani A. 58. Soleymani M. 59. Soleymanirad J. 60. Talayee T. 61. Yousefi B. 62. Zarnani AH.

C- Genetics 1. Ghasemi N. 2. Ghafari SR. 3. Gourabi H. 4. Pouresmaili F. 5. Taslimi H.

6. Modaresi MH. 7. Nowroozinia M. 8. Rezapour S. 9. Sheikhha MH.

D- Urology 1. Abbasi H. 2. Amir Jannati N. 3. Ayati M. 4. Babolhavaeji H. 5. Fahimi R. 6. Farahi F. 7. Hosseini SJ. 8. Jamshidian H. 9. Kazemeini M. 10. Moin MR. 11. Monaheji F. 12. Nowroozi MR. 13. Poormand GhR.

14. Pooyan O. 15. Radkhah K. 16. Saheb Kashaf S. 17. Sedighi Gilani MA. 18. Shakeri S. 19. Shamsa A. 20. Vahidi SD. 21. Yari H. 22. Ziaei AM. 23. Zeyghami Sh. 24. Hosseini MM. 25. Amirzargar MA. 26. Akhavi zadegan H.

E- Midwifery 1. 2. 3. 4. 5. 6. 7. 8. XII

Abad M. Abdi M. Adib N. Ahmadi M. Alizadeh F. Amir Ali Akbari S. Corpi M. Ebdali KH.

9. Ebrahimitavani M. 10. Dolatian M. 11. Forohari S. 12. Ghiasi P. 13. Hadipoor L. 14. Hajizade Z. 15. Jannatiatai P. 16. Jamshidi Manesh M.

17. Janghorban R. 18. Jan Nesari SH. 19. Kariman NS 20. Keramat A. 21. Khodakarami N. 22. Malakouti M. 23. Maleki H. 24. Merghati E. 25. Mir-Ghavamedin N. 26. Mir Mohammad Ali M. 27. Mir Mowlayee SH. 28. Mohammadaleyha F. 29. Nahidi F. 30. Ozgoli G. 31. Rahmanian F. 32. Rahmanpur E. 33. Roosta F.

34. Shafei SH 35. Sadeghi M. 36. Salehi S. 37. Sharegh L. 38. Sheikhan Z. 39. Simbor M. 40. Tehranian N. 41. Torkzahrani SH. 42. Zendezaban N. 43. Yazdan Ashouri M. 44. Vali Zadeh M. 45. Vasegh Rahim Parvar SF. 46. Vojodi E. 47. Karimian NS. 48. Keramat A. 49. SHafiee SH.

F- Others 1. Dejkam L. 2. Modaber MH.

3. Sadeghi MH.

XIII

Abstracts of the 17th Congress of Iranian Society for Reproductive Medicine

Contents

ORAL PRESENTATIONS .......................................................................... 1 POSTER PRESENTAIONS ...................................................................... 31 AUTHORS’ INDEX ...................................................................................... 83

XIII

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

A- Oral Presentations 1- Infertility, Gynecology O-1 The luteal phase defect of stimulated cycles and the possible solutions Mousavi Fatemi H. V.U.B./C.R.G., Laarbeeklaan 101, 1090 Brussels, Belgium. Email: [email protected]

The luteal phases of all stimulated IVF cycles are abnormal. The main cause of the luteal phase defect (LPD) observed in stimulated IVF cycles is related to the multifollicular development achieved during ovarian stimulation. It can be postulated that the main cause of the luteal phase defect in stimulated IVF cycles is the supra-physiological levels of steroids secreted by a high number of corpora lutea during the early luteal phase, which directly inhibit the LH release via negative feedback actions at the hypothalamic-pituitary axis level, rather than a central pituitary cause or steroidogenic abnormality in the corpus luteum. To correct the LPD in stimulated IVF cycles, hCG or progesterone can be administered. HCG is associated with a greater risk of OHSS. Natural micronised progesterone is not efficient if taken orally. Vaginal and intra muscular progesterone do have comparable implantation, clinical pregnancy and delivery rates. However, due to severe site effects, intramuscular progesterone administration should be avoided. Future studies should focus on drugs which increase the LH production during the luteal phase. Key words: Luteal phase defect, Luteal phase support, IVF, Ovarian stimulation.

O-2 Psychological aspect of infertility Beyraghi N. Department of Psychosomatic, Neurofunctional and Neurosurgery Research Center, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]

The inability to conceive children is experienced as a stressful situation by couples all around the world and infertility is a devastating experience, especially for women. Evidences indicate

important QOL impairments in infertile women. Among men, it does not appear to be intense. Also little attention has been paid to the psychological status of infertile men from developing countries who have been traditionally stigmatized as feeble and ineffective. The consequences of infertility are manifold and can include societal repercussions and personal suffering. Health professionals need to consider all aspects of holistic care when caring for couple with fertility problems, Cultural; psychological, religious and spiritual dimensions of infertility have received little attention in our society. Advances in assisted reproductive technologies, such as IVF, can offer hope to many couples where treatment is available, although barriers exist in terms of medical coverage and affordability. The medicalization of infertility has unwillingly led to a disregard for the emotional responses that couples experience, which include distress, loss of control, stigmatization, and a disruption in the developmental trajectory of adulthood. Evidence is emerging of an association between stress of fertility treatment and patient drop-out and pregnancy rates. Fortunately, psychological interventions have been shown to have beneficial effects for infertility patients. Key words: Psychological status, Infertility, IVF.

O-3 Endocrine and male infertility Amouzegar A. Department of Endocrine, Research Institute for Endocrine Sciences, Shahid Beheshti Uuniversity of Medical Sciences, Tehran, Iran. Email: [email protected]

Infertility is an emotionally charged problem affecting an estimated 15% of all couples. The man should be evaluated concurrently with the woman, since a male factor is the primary or contributing cause in 40% to 60% of cases. The evaluation of the infertile male continues to be a clinical challenge of increasing significance with considerable emotional and financial burdens. Many physiological, environmental and genetic factors are implicated. The infertility practitioner should have a thorough understanding of the advantages and limitations of various laboratory tests as well as the indications, costs and success rates of all treatment options. A complete medical history in conjunction with a focused examination can allow for an appropriate choice of laboratory and imaging studies. The semen analysis is a

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

1

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

crucial first step, but it is by no means sufficient to determine cause or dictate therapy. Azoospermia factor (AZF) microdeletions of the Y chromosome, which occur in 1-55% of infertile men, are closely associated with severe spermatogenic failure and represent the most frequent molecular genetics causes of azoospermia and severe oligozoospermia. Researches on AZF and its related genes, approaching the mechanisms of spermatogenic failure at the molecular level, are of great significance for the diagnosis, treatment and prognosis of male infertility. The detection of AZF microdeletions can provide scientific basis for correct diagnosis and reasonable. Klinefelter,s syndrome and Y chromosome microdeletions are the most prevalent disorder, together accounting for 10-20% of patients evaluating for genetic cause of male infertility. Other cause of primary testicular failure such as undescended testis and orchiti should be considered as certain causes of infertility. Hypogonadotropic hypogonadism due to pituitary adenoma, panhypopituitarism hyperprolactinemia or idiopathic causes is another treatable etiology of male infertility. For part of infertile patients a genetic factor will be the underlying cause of the problems. The studies, focusing on men with fertility problems, can be subdivided into three groups: studies on deletions on the long arm of the Y chromosome, studies on X-linked genes and studies on autosomal genes. It is obvious that Yq microdeletions should be considered as a cause of male infertility. Therefore, couples with a component of male factor infertility need a systematic evaluation directed at the male partner to maximize their reproductive potential. Key words: Male factor, Infertility, Y chromosome.

O-4 Endocrine aspects of infertility Kalbasi S. Department of Endocrine, Research Institute for Endocrine Sciences, Shahid Beheshti Uuniversity of Medical Sciences, Tehran, Iran. Email: [email protected]

Infertility is defined as the inability to conceive after 12 months of unprotected sexual intercourse. The National Survey of Family Growth reports a 14% rate of infertility in the United States in married women aged 15-44 years. Infertility can be attributed primarily to male factors in 25%, female factors in 58% and is unexplained in about 17% of couples.

2

The most common cause of female infertility is abnormalities in menstrual function (46%). These disorders include ovulatory dysfunction and abnormalities of the uterus or outflow tract. A careful history and physical examination and a limited number of hormonal tests will help to determine whether the abnormality is: 1/ hypothalamic or pituitary [low FSH, LH and estradiol with or without an increased PPL (51%)], 2/ PCOS (30%), 3/ ovarian (low estradiol with increased FSH) (12%), or 4/ uterus or outflow tract abnormality (7%). Key words: Infertility, Hypothalamic, Pituitary.

O-5 Obesity and female fertility Hekmatdoost A. Department of Clinical Nutrition and Dietics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]

Although under-nutrition is the major cause of disease and death in developing countries, obesity is the most common nutrition problem to affect reproduction in developed countries. Since the balance of energy is essential for female reproduction, appetite and the reproductive axis are closely linked to nutritional status. As a safeguard against untimely reproduction due to malnutrition, ovarian activity is suppressed in women with eating disorders through pathways in the hindbrain. It is the balance between energy uptake and expenditure that is crucial more than the body fat mass, thus recovery of ovulation may occur after a small percentage modulation in weight. Fat tissue is metabolically active and its most important activity is modifications of steroid hormones and secretion of many proteins such as adipokines. Many of these factor influences are reproductive hormones; moreover, the secretions of the fat can affect the function of the reproductive system. Many obese women conceive and go through pregnancy without incident; however, being overweight or obese impairs natural fertility and interferes with the response to the assisted reproduction treatments. The mechanisms are not obvious, but the association between insulin resistance and anovulation may contribute. Management should involve a healthy diet and lifestyle to precede or supplement induction of ovulation. Such lifestyle programs will be effective with intensive effort. Fortunately ovulation is often achieved after 5-10% weight modification, perhaps because of the alteration in energy balance. Among

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

overweight and obese pregnant women, there is an increased likelihood of spontaneous pregnancy loss, mainly in the first trimester as well as pregnancy complications (pregnancy-induced hypertensive diseases and gestational diabetes) and pregnancy outcomes. Currently, prevention of obesity is one of the most important programs for health promotion. Thus, we need medical educations for doctors on the art of preventing obesity and managing weight loss in women with established overweight and obesity, and patient education regarding the role of obesity in reproduction, promotion of healthy lifestyle for the woman, her partner and their future family with emphasis on reducing central adiposity and improving metabolic fitness rather than simply on weight and BMI reduction.

Results: there was a significant reduction of mean follicular sizes in each group after medical intervention (7.63±2.11 vs 4.30±0.92 in groupA and 8.73±1.96 vs 4.13±1.11 in group B). Two pre –treatment and specially Estradiol cause the attenuation of follicular size discrepancies but this was not significant. Both E2 and GnRH antagonist significantly decreased serum FSH and inhibin B levels. Serum E2 level significantly increased in E2/day3, but did not change on GnRH antagonist/day3. Conclusion: Both pre-treatment of E2 and GnRH antagonist in luteal phase before antagonist protocol can reduce the follicular sizes and discrepancies, but this matter and their effect on oocyte yield, endometrial quality and COH outcome need further study with more sample size.

Key words: Obesity, Female fertility, Health.

Key words: antagonist.

O-6 The luteal phase estradiol versus luteal phase GnRH antagonist: their effects on antral follicular size coordination and basal hormonal levels Rashidi B1, Nasiri R1, Rahmanpour H1,2, Shahrokh Tehrani- nejad E1, Deldar M1. 1 Vali-e-Asr Reproductive Health Research Center, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 2 Department of Obstetrics and Gynecology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. Email: [email protected]

Introduction: The differential efficacy between antagonist protocols with routine long GnRH agonist can partly be due to the preexisting differences in the early antral follicles before ovarian stimulation. This study was performed for comparing the effect of luteal estradiol administration with premenstrual GnRH antagonist administration in antral follicular size coordination and basal hormone levels. Materials and Methods: In this randomized clinical trial 30 women with infertility and candidate for ICSI were randomized to receive oral estradiol 4mg/day from day 20 of previous cycle or 3 mg cetrorelix acetate single injection, subcutaneously in luteal phase of previous cycle and characteristic of antral follicles with TVS and serum FSH, estradiol and inhibin B levels were assessed in day 3 of cycle before and after treatment.

Follicular synchronization, Estradiol, GnRH

O-7 Evaluating the effect of intra-vaginal seminal plasma insemination on emberyo implantation and early abortion in infertile women undergoing ICSI Golmohammadlou S1, Hajishafiha M1, Yekta Z2, Fieroozy E3. 1 Department of Obstetrics and Gynecology, Urmia University of Medical Sciences, Urmia, Iran. 2 Department of Social Medicine, Urmia University of Medical Sciences, Urmia, Iran. 3 Department of Obstetrics and Gynecology, Motahari Hospital, Urmia University of Medical Sciences, Urmia, Iran. Email: [email protected]

Introduction: Semen in a co factor in preparing endometrium for embryo implantation. This is in contrast with public believed that immune response to antigen in ejaculated semen will disrupt fertility and pregnancy. New findings support the opposite theory, which indicates that insemination actives maternal immunologic mechanisms which have a positive effect on fertility Materials and Methods: In this study , a groups of 140 couples who had an indication for intra cytoplasmic sperm injection (ICSI) had on embryo implantation 48-72 hours after ovum aspiration. Followup methods included a β HCG measurement in day 14 and sonographic evaluation in 6th and 12th week. The semen was previously collected and refrigerated, and was prepared for transfer 30-60 minutes before embryo, and was transferred after that. There was no significant correlation between ages, etiology of infertility, type of infertility

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

3

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

history of previous IVF, number of embryos, type of embryo, in both groups. Results: Implantation rate was 25.5% in the control group and 24.3% in the study group (p=1) early abortion rate was 11.1% in the control group and 18.7% in the study group (p=0.5). There was no significant difference in implantation rate and early abortion rate between both groups. Considering the limitations of this study and the considerably little sample size and the limited research conducted about this subject especially our contry. Conclusion: We suggest that more studies with a large sample size and proper training for couples be preformed. Key words: Implantation, Abortion, Infertility.

O-8 Ovarian stimulation pregnancy rate of FET

protocols

and

Mansouri M, Sabouri E, Aram R, Fadavi Islam M, Rustaii H, Khalilifar H. Novin Infertility Center, Mashhad, Iran. Email: [email protected]

Introduction: Is there any differences between the pregnancy rate of frozen-thawed embryo transfer (FET) in agonist and antagonist protocols. The aim of this study was to assess the effect of gonadotropin-releasing hormone (GnRH) antagonists/buserelin on embryos by comparing the outcome of cryopreserved-thawed embryo transfers for cycles using a GnRH agonist or GnRH antagonist/buserelin protocol for the controlled ovarian stimulation in the oocyte retrieval cycle. Materials and Methods: We studied the frozen embryos from 80 women undergoing ICSI which were administered either HCG/GnRH agonist long protocol (Group A, n=52) or GnRH/buserelin antagonist protocol (Group B, n=18) that were thawed in Novin Infertility Center (Mashhad, Iran) from March 2010 to June 2010 (there were no significant statistically differences between two groups in the age and male factor). Frozen embryo transfer pregnancy rate of these two groups were evaluated. Data analyzed by Fisher test (SPSS version 7). Results: pregnancy rates were similar independent of whether they resulted from the long – protocol cycles with HCG (46.2%) or from the antagonist protocol cycles with buserelin (38.9%). Conclusion: Frozen-thawed embryo derived from the GnRH agonist cycles have the same pregnancy rates to those derived from the GnRH/buserelin antagonist cycles, Furthermore, in fresh embryo,

4

lower pregnancy rates following GnRH/buserelinantagonist protocols compared with long GnRH/agonist protocols have been reported, The differences might be due to an impact on oocyte number and quality or on the endometrium, not embryos quality, so according to this point in the patient with the risk of OHSS who received GnRH/buserelin antagonist protocol, it would be better to freeze all the embryos and then transfer them in a better situation . Key words: Frozen-thawed embryo transfer, GnRH agonist, GnRH antagonist, IVF, ICSI.

O-9 Intravenous ascorbic acid (vitamin C) administration in abdominal myomectomy: A prospective clinical trial Pourmatroud E, Hemadi M. Department of Obstetrics and Gynecology, Ahvaz Jondishapur University of Medical Sciences, Ahvaz, Iran. Email: [email protected]

Introduction: To assess the advantage of ascorbic acid (vitamin C) administration in abdominal myomectomy. Materials and Methods: A total of 102 patients were enrolled in this prospective clinical trial, in two groups. Group A had several injections of Ascorbic Acid during myomectomy, but group B had myomectomy without any intervention. The time of operation, volume of bleeding, days of hospitalization, post operative complications and rate of blood transfusion were compared between two groups. Results: The volume of bleeding, duration of operation, days of hospitalization in group A were significantly less than group B (p-value: 0.001). The chance of blood transfusion in group B was about 2.5 times more than group A (7.7% vs. 18%). There was a significant correlation between the volume of bleeding and post operative complications in both groups (p value in group A, 0.03 and in group B, 0.004). Conclusion: Ascorbic Acid (vitamin C) either as a prophylactic agent or a therapeutic option could be useful in all of gynaecologic and obstetrics attempts without any serious side effects. Key words: Ascorbic Acid, Gynaecologic, Operation.

O-10 Transfer of cervical infection to the uterine cavity during ET Ziaie T, Sharomy H, Savadzadeh Sh. Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Rasht, Iran. Email: [email protected]

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Introduction: The aim of this study was to evaluate the influence of catheter type on transferring of the cervical infection to the uterine via ascending rout during embryo transfer and in the ART results.. It is established that the endometrial inflammation and infections may affect on the implantation rate and decrease the pregnancy rate. Materials and Methods: In a prospective randomized clinical trial, 100 patients aged 23–40 (33.23±1.6) years undergoing ICSI treatment were selected for this study. During embryo transfer, separate samples were collected for microbial examination from the following sites: the cervix and exocervix before washing by the ringer’ lactate for direct smear evaluation and culture, the tip of the catheter, and the external and middle sheets. All the samples were separately cultured to identify any bacteria or yeast present. Then patients diveied in two groups randomly for 2 kinds of the catheters Cook and Gaurdia catheter of the cook company. After emryo transfer the tip of sheets cut and sent for cultures. Results: Direct smear showed WBC in the outher sheet was positive for Entrobacteriaceae (22.2% vs 51%) and Staphylococcusspecies (17.6% vs 44%) were significantly lower than those in the cook catheter without gaurdia (p 35 mm in the clomiphene group was seen in 7 women and in the leterozole group in none (p=0.014). The follicle diameter > 18mm in the clomiphene group was seen in 18 women and in the leterozole group in 22 women (p=0.154). Conclusion: The number and the size of mature follicles were significantly more in the clomiphene group. The pregnancy rate in letrozole group was higher than that in the clomiphene group and the difference was significant statistically. Nonsignificant difference was detected in endometrial thickness between two groups. This Study found superiority in letrozole for inducing pregnancy in women. Letrozole might be an acceptable alternative to clomiphene citrate to induce ovulation and pregnancy in PCOS patients. Key words: Clomiphen, Letrozole, Polycystic Ovary.

Key words: OHSS, Fertilization, Implantation.

P-33 Induction ovulation in polycystic ovary patient with clomiphene citrate and letrozole

P-34 A successful intrauterine pregnancy in a patient with bilateral fallopian tubes occlusion, a case report Moradan S.

Keikha F, Shahraki Mojahed B. Department of Obstetrics and Gynecology, Zahedan University of Medical Sciences, Zahedan, Iran.

Department of Obstetrics and Gynecology, Amir University Hospital, Semnan University of Medical Sciences, Semnan, Iran.

Email: [email protected]

Email: [email protected]

46

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Introduction: A 23 years old woman with history of infertility for 4 years duration was referred. Materials and Methods: Infertility workup consists of hormonal evaluation, sonography, sperm analysis and hysterosalpingography were performed. Results: Sonography and bilateral uterine tubes occlusion in hysterosalpingography were present. The patient undergone ovulation induction with clomiphene citrate, letrozole and HMG about 8 cycles before but pregnancy did not happen. Diagnostic laparoscopy for infertility evaluation was done. In laparoscopy the uterus was normal; there was no adhesion or endometrioses lesion in pelvic cavity. Ovaries had PCOD pattern. So, cauterizations of every ovary in 4 points were done. Then the patency of both tubes was evaluated by methylene blue dye injection. But even with several times try and more dye there was no spillage of dye from any tubes. So, the operation was finished and use of assisted reproductive technology for pregnancy was recommended to the patient. One month later, the patient referred with history of 3 days retard in her menstruation date and the pregnancy test was positive .ten days later there was normal 7 week gestational sac inside the uterine cavity with fetal heart beat. She had an uneventful pregnancy and cesarean section was performed in 40w+3d and a boy newborn with Apgar score 9 was delivered. Conclusion: This case is noticeable because in both hysterosalpingography and laparoscopy there was bilateral uterine tubes occlusion but the patient had normal pregnancy. Key words: Uterine Hysterosalpingography.

tubes

occlusion,

intra venues, sub cotaneous or new methods such as patient control analgesia (PCA). As it is new method, research decided to compare efficacy of these 2 methods. Materials and Methods: This is a prospective clinical trial study which has done on primi parous with full term, single pregnancy who was candidate for elective cesarean in Sepahan shahr hospital of Isfahan in 2010. Excluding criteria was using another drugs, essential disease, not to permit, dizziness; coma .number of cases was 44 in each group which had been selected simple. In recovery and surgery ward patients were evaluated about vital signs- drugs side effects. Pain score evaluated by visual analog scale (VAS) by patients. Satisfaction of pain relief asked from patients. Results: Petidin was significantly more effective for pain relief than PCA in 1, 8, 12 hours after surgery (p0.05) with haemoglobin in the first half of gestation by the Pierson's correlation coefficient. For more accuracy results, the linear regression was run and showed the rate of iron, folate, vitamin B12, and calcium in the diurnal consumption does not have any significant correlation with the rate of haemoglobin in the first half of pregnancy. Conclusion: According to the results of this study and the lack of correlation between nutritional ingredients for synthesis of haemoglobin, which was probably due to rather low samples, it is suggested that more research with larger samples, are needed to perform in order to establish these relationships. Key words: Pregnancy, Haemoglobin Levels, Diet, Food Frequency Questionnaire.

P-110 Assessment of the relationship between daily protein intakes with BUN and Cr in first trimester Babaei M1, Soltanmorady S1, Banaem L2, Ghodsi D3.

Moghadam

1 Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. 2 Obstetrics Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. 3 Nutritional Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]

Introduction: This study investigates the relationship between daily intakes of protein in pregnant women and BUN, Cr levels in the first trimester of pregnancy. Materials and Methods: This cross sectional study was conducted on 436 18-35 year-old pregnant women, whose gestational age was equal or less than 20 weeks and singleton pregnancy who attended prenatal clinics in the hospitals of Shahid Beheshti, Iran and Tehran Universities in 2010. The prenatal clinics were selected by stratified cluster sampling. All subjects completed two questionnaires that included demographic characteristics and food frequency questionnaire (FFQ). Received food and calories of each person was determined by using nutritional software. To descriptive tests, Pearson's correlation coefficient and linear regression analysis, we used SPSS Version16. Results: In this study, no relation between daily protein intake of dietary (p>0.05) with BUN, Cr first trimester in pregnant women has been seen. To more accurately evaluate, we run linear regression and no significant relationship among intake proteins, BUN, Cr first trimester (p>0.05) and parity, chronic diseases, smoking and maternal age was revealed. Conclusion: According to the results, there wasn’t any relationship between the daily protein intake and BUN, Cr first trimester that probably was due to comparatively low samples. It is suggested that more studies with larger samples be performed to establish these relationships. Key words: Food Frequency Questionnaire, Daily Protein, BUN and Cr levels, first half of pregnancy.

P-111 The effect of education on knowledge about methods of contraception and sexual health in couples referred to the Health Center Akbarbegloo M, Habibpour Z, Bayrami R Faculty of Nursing and Health, Pediatric Nursing, Urmia University of Medical Sciences, Khoy, Iran. Email: m.akbarbegloo @ yahoo.com

Introduction: Unwanted pregnancies are one of the important problems of countries. In our country despite the numerous efforts of authorities and cover a wide family planning, unwanted pregnancies and the consequences of that such as infectious abortions are common problems. Unwanted pregnancies are often due to lack of use or uncorrected use of common methods of contraception due to low knowledge and

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

81

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

information. Therefore, its researchers have done to assess knowledge of young couples about contraceptive methods. Materials and Methods: This study was an interventional study that was conducted in 1389. Environmental research was center health and temperament of Khoy city and the study populations were young couples in the health center that comprised within two months. Simple sampling done and available sample included 40 persons. Data collection tool was (teenage knowledge of contraception and sexual heath). The scientific validity has done by five faculty members and content validity determined by using Test-Retest (=0.79). Results analysis was investigated by using SPSS software before and after training. Results: The results showed that participating couples in all areas of contraception had moderate

82

and poor information. The least information was about emergency contraception, and most information was about menstrual period. T test showed the significant difference before and after training (p=0.001), so that couples in all areas of knowledge after the training had reached the desired or medium level. Conclusion: Considering the average knowledge about the emergency methods and poor knowledge of some cooperation about useful items, including the proper time to use the emergency contraceptive. This point shows that strengthening the quantitative and qualitative aspects of this centers can play a vital role in giving information, establish correct beliefs about contraceptive methods and all of this should be lead to efficient application of these methods and reduction in failure contraceptive methods. Key words: Education, Prevention, Pregnancy, Knowledge.

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Authors Index: Abasi Z. Abbasi H. Abbasi M. Abbaszadeh F. Abdi Rad I. Abdollahifard S. Abdollahiyan P. Abdollahiyan Z. Abedi HA. Abedian Z. Absalan F. Absalan N. Aflatoonian R. Afsoon Y. Agha Hosseini M. Aghlmand S. Ahmadi Jalali Mogaddam M. Ahmadi Sh. Ahmadipour Sh. Ahmadnia E. Akbarbegloo M. Akbari Asbagh F. Akhbardeh M. Al-Akoum Sh. Aleyasin A. Al-Hasani S. Aliabadi E. Aliyan Moghadam N. Alizadeh L. Amanlou M. Amanpour S. Amini L. Amini M. Amini sadr M. Amir I. Amiri Fard. Amiri M. Amiri S. Amirzargar H. Amirzargar MA. Amirzargar N. Amouzegar A. Aparnak F. Aram R. Arjmandifar M. Asadi F. Asgari Z. Asghania M. Askari L. Asl Toghiri M. Ataei M. Atashkhoyi S. Atrkar Roshan Z. Ayati M. Azarnia M. Azhari S. Azizi F. Azizi H. Azodi P. Babaei M. Babbolhavaeji H.

P-92 O-49 P-28 P-106 P-69 P-8 P-27, P-30 P-38 P-105 P-93 O-31 O-52 O-50 P-26 O-43, P-25 P-26 O-28 O-13 O-47 P-94 P-111 P-11, P-12 P-2 O-17 O-36, O-43, P-25, P-57, P-67, P-71 O-16 O-33 P-103 P-31, P-60 P-52 P-86 P-100 P-101, P-104 O-36, P-71 O-37 P-70 O-23 O-31 O-40 O-40 O-40 O-3 P-95 O-8, P-82 O-51, O-56 P-70 P-54 P-13, P-27, P-29 P-30, P-38 P-101 O-55 O-32 O-11 P-13 O-41 O-25, P-48 P-19 P-96, P-97 O-20, O-53 P-55 O-60, P-108, P-109, P-110 O-40

Baboli S. Bagheri A. Bagheri K. Bagheri M. Baghery M. Bahadoran H. Bahadori MH. Baharvand H. Bahri N. Bakouei S. Basiri A. Bayat PD. Bayrami R. Behtash N. Beigi Boroujeni M. Berjis K. Beyraghi N. Bina I. Borhani M. Broomand F. Broumand F. Chamani-Tabriz L. Chaparzadeh N. Chehreh H. Chiti A. Chobsaz F. Daeichin S. Darabi M. Davari S. Davari-Tanha F. Davoodi A. Davoodi S. Davoudi A. Deemeh MR. Deldar M. Delpisheh A. Dkhanchy F. Dkhanchy M. Dokhanchi M. Doorfeshan P. Ebadi P. Ebrahimi A. Ebrahimi B. Ebrahimi M. Ebrahimzade S. Ebrahimzadeh S. Eftekhar F. Eftekhari Yazdi P. Eimani H. Erfani N. Erfanian Ahmadpoor M. Eslami B. Esmaili Z. Esteves SC. Ezabadi Z. Fadavi Eslam M. Fadavi Islam M. Fadavi Islam R. Fallahi P. Farahmand M. Faraji R. Farivar Sh. Farrokhi A.

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

O-34 P-106 P-5, P-22 P-69 P-41 O-25 O-19, P-54 O-20, O-24 O-58 P-99, P-100, P-102 O-40 P-91 P-111 P-37 O-21 P-16 O-2 P-20 P-15 P-26 O-15 P-15 O-38, P-72, P-73 O-59 P-37 O-30 O-47 O-27, P-65 O-46 P-24 P-44, P-62 O-58 O-36, P-67, P-71 O-49 O-6 P-3 P-53 P-46 P-40, P-50 P-87 P-5 P-68 O-24 P-11, P-12 P-19 P-95 P-5 O-24 P-48, P-66 P-89 O-53 P-10 P-63 O-18, O-39 P-31 P-32 O-8 P-82 P-25, P-57 P-96, P-97 P-29 O-23 P-64

83

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Farzadi L.

Fathizadeh N. Fattahi S. Fayazi M. Fazel M. Feizinia S. Fereidoni F. Fieroozy E. Firoozi A. Foroozanfard F. Forouzandeh M. Forouzandeh Moghadam M. Gasemzadeh A. Ghaderi A. Ghafarzadeh M. Ghahiri A. Ghanbar AA. Ghanbari A. Ghandi S. Ghannadi A. Ghannady AR. Ghasemi M. Ghasemi N. Ghasemi rad M. Ghasemian F. Ghaseminejad A. Ghasemzadeh A. Ghavami MA. Ghodsi D. Ghodsi N. Ghodsi Z. Ghoraeian P. Ghorbani R. Golmohammadlou S. Goshtasbi A. Gourabi H. Granmayeh M. Habibpour Z. Haddad E. Hadi N. Haghani L. Haghshenas Emami R. Haidary A. Haj Seyed Javadi E. Hajishafiha M. Hajizade E. Hajshafiha M. Halvaei I. Hamdi BA. Hasanzahraei P. Hashemi M. Hashemi S. Hassani F. Hassanpour S. Hayati N. Hekmatdoost A. Hellani A. Hemadi M. Hemati T. Hooshmand F. Hoshmand F. Hosseini F.

84

O-27, O-38, P-7, P-42, P-65, P-72, P-73 P-105 P-63 O-21 P-21 P-8 P-35 O-7 O-38, P-72, P-73 O-12 P-85 O-29 P-7, P-42 P-89 P-107 P-35 P-59 P-91 P-21 O-31 O-26 O-54, P-35 O-49 O-15 O-19 P-11 O-38, P-42, P-72, P-73 O-34 O-60, P-108, P-109, P-110 P-99, P-102 P-90 P-57 O-30 O-7 P-9,P-99,P-100, P-101, P-102 O-42 O-57 P-111 O-17 P-102 O-44, O-45, P-4, P-49 P-41 P-47 P-1 O-7 P-102 O-15 P-39 P-80 P-105 P-4, P-49 P-98 P-60 O-35 O-32 O-5 O-17 O-9 P-24 P-53 P-41, P-43, P-58 O-59

Hosseini M. Hosseini Moghaddam SM. Hosseini Z. Hossieni A. Houshmand M. Iran Ghodsi Z. Jabalameli P. Jabari F. Jahangiri N. Jahanpour F. Jahanpour NS. Jalilian A. Jamalzadeh F. Jamshidian H. Janan A. Janghorbani M. Javadi Gh. Javadian P. Johari H. Joneidi E. Jorsaraei S. Kabirian M. Kafilzadeh F. Kalantar SM. Kalbasi S. Kamyabi Z. Karami Shabankareh H. Kargar Jahromy Ho. Kargosha A. Karimi Ansari N. Karimi H. Karimi Jashni H.

Karimi M. Karimi Zarchi M. Karimmpoor N. Karrgarjahromy H. Kashani M. Kazemi M. Kazemnegad A. Kazemnejad A. Kazerooni M. Keikha F. Keshtgar S. Khaiatian N. Khaje E. Khaki AA. Khalili Far H. Khalili MA. Khalilifar H. Khatamsaz M. Khazaei M. Khodabakhshi SH. Khodadoost L. Khosravi KH. Koohpeyma F. Koohpeyma R. Koruji M. Lakpour M. Lamyian M. Lashgarbluki T. Madani T. Mahbub S.

P-15 O-40 P-26 P-30 O-48 O-55 O-41 P-54 P-10, P-23 P-55 P-55 P-3 O-31 O-41 O-20, O-50 O-54 O-36, P-71 P-24 P-62 O-53 P-63 P-93 P-79 O-48 O-4 P-10 P-74, P-75, P-76, P-77, P-78, P-79 P-61 O-45, P-4, P-49 O-38, P-72, P-73 O-26 P-40, P-41, P-43, P-44, P-45, P-46, P-50, P-53, P-58, P-62 P-29 P-36, P-37 O-15 P-56 P-88 O-25 O-51, O-56 O-14 O-31 P-33 O-33 O-12 P-7, P-42 P-80, P-59 P-82 P-39 O-8, P-32 O-34 O-30, P-91 P-23 O-58 P-25 P-56, P-61 P-61 O-20 O-50 P-99, P-100, P-101, P-102 P-88 P-23 P-32

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Mahmoudi R. Mahram B. Makoolati Z. Maleki A. Malekzade Shiravani S, Malmasi S. Mansoori M. Mansouri M. Mansuri Turshiz M. Mayahi O. Mazaheri pour Z. Mazaheri Z. Mazlom SR. Mazloomi P. Mazloomzadeh S. Mehdizadeh A. Mehrabipoor F. Mehrafza M. Mehran N. Mehrzad Sadaghiani M. Mirblouk F. Mirfakhraei R. Mirfakhraie R. Mirfakhraie S. Mirhosseini Z. Mirkhani MH. Mirmoezy M. Mirshamsi M. Mirteimoori M. Mirzajani R. Moadabshoar L. Moezeni M. Moghadam Banaem L. Moghadami-Tabrizi N. Moghaddam Banaem L. Mohabati Mobarez A. Mohamadinia N. Mohammad Tabar Z. Mohebi S. Moini A. Momeni HR. Montazeri M. Moosavi M. Moradan S. Moslehi M. Mostafa Gharabaghi P. Mousavi A. Mousavi Fatemi H. Movaghar B. Movahedin M. Mowla S. Mozafari S. Mozdarani H. Muhammadnejad S. Naeimi S. Najafi R. Najmadini N. Nakhostin Ansari N. Namavar MR. Nanbakhsh F. Nasiri E. Nasiri R. Nasr-Esfahani MH. Nasri S.

P-51 P-93 O-29 P-94 P-41, P-43, P-58 P-27, P-38 O-53 O-8, P-82 P-32 P-51 O-57 P-86 P-93 P-26 P-94 O-27, P-65 O-46 P-27, P-30, P-38 P-28, P-105, P-106 O-38, P-72, P-73 P-13 O-32 O-48 P-70 O-49 O-33 O-58 P-74, P-75, P-76, P-77, P-78 P-14 P-70 O-40 P-87 O-60, P-103, P-108, P-109, P-110 P-24 P-104 P-83 O-52 P-27, P-30, P-38 O-58 P-10 P-66 O-32, O-48 P-19 P-34 P-13 P-8 P-37 O-1 P-64 O-29, P-83, P-84, P-86 P-84 P-60 P-57 P-86 P-89 O-37 P-45 P-16 O-33 P-26, P-69 O-19 O-6, P-32, P-82 O-49 P-54

Nasrollazadeh M. Neisani Samani L. Nemati A. Nikoofarjam N. Nikpuri P. Nikpuri Z. Noori M. Noruzinia M. Nouri M. Nowroozi MR. Omani Samani R. Oskouian H. Oskuian H. Ostad Khalil F. Ostadkhalil F. Oudi M. Pacey A. Parkami MA. Parkami MR. Peirouvi T. Peyghambarl F. Peyman A. Peyman H. Poormand N. Pourdadash Amiri P. Pourmand Gh. Pourmatroud E. Poursadegh Zonouzi A. Pourteymour fard Tabrizi F. Pouyan O. Radkhah K. Rafati P. Rahbarizadeh F. Rahimian T. Rahimipour L. Rahmani E. Rahmanpour H. Ramezani M. Ramezani Tehrani F. Ramezani Tehrani H. Ranjbaran A. Ranjbaran AR. Rasekh Athar R. Rasekh Jahromi A. Rashidi B. Rashidi MR. Rashki Ghaleno L. Rastgou Z. Razi MH. Reisian F. Rezaeepoor A. Rezaei Habib Abadi Z. Rezaeian Z. Rezazadeh Valojerdi M. Rezazadeh Valujerdi M. Robab Allameh M. Roodi M. Roshangar L. Roshankhah SH. Rustaii H. Saber M. Saberi F. Sabetkam S. Sabouri E. Sadaghiani M. Sadaghiani Mahzad M.

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

P-38 O-59 P-36 P-107 P-38 P-27, P-30 O-54 P-84 O-27, P-7, P-42, P-65 O-41, O-42 P-31, P-60 O-13 P-32 O-45 O-44, P-4, P-49 P-30 O-50 P-56 P-61 P-47 P-85 P-92 P-3 P-12 P-63 O-48 O-9 O-38, P-72, P-73 P-18 O-43, O-50 O-41, O-42 P-107 P-86 P-38 O-27, P-65 O-13 O-6 P-54 P-96, P-97 P-98 O-42 O-41 P-17 O-46 O-6 P-7, P-42 O-22 P-83 P-39 P-99, P-100, P-102 O-14 O-57 P-57 O-22, O-24, P-52 P-85 P-98 P-62 O-35, P-59, P-80, P-81 O-30 O-8, P-82 P-66 O-12 P-81 O-8, P-82 P-18 O-11

85

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Sadeghi H. Sadeghi M. Sadeghian F. Sadeghzadeh Oskouei B. Sadr Nabavi R. Saeedi H. Saeidi S. Safari M. Safary K. Safdarian L. Saghafi H. Sahraei H. Sahraei S. Sakhavar N. Sakhinia E. Salehi. Salehin Sh. Salehnia M. Salmanian B. Salsabili H. Salsabili N. Samieizadeh Toosi T. Samsami Dehaghani A. Sarvi F. Savadzadeh Sh. Seddighi Gilani M. Sedighi A. Sedighi MA. Sehat Z. Seifi B. Seyed Fatemi N. Seyedoshohadaei F. Shaaker M. Shademani K. Shah Hoseini. Shahgeibi Sh. Shahnazi V. Shahraki Mojahed B. Shahrokh Tehrani- nejad E. Shahverdi A. Shakiba M. Shams Lahijani M. Shapouri F. Sharbatoghli M.

86

P-56, P-61 P-10 P-101 P-59 P-95 O-43 O-50 O-44 P-104 P-25 P-28 O-25 P-64 P-14 O-38, P-72, P-73 P-67 O-14 O-21, P-85, P-87 P-24 P-16 O-32, O-48, P-16 O-52 P-89 P-25 O-10 O-50 P-16 O-42 P-9 O-53 O-59 P-6 O-27, P-65 P-27, P-30, P-38 P-64 P-6 O-27, P-7, P-42, P-65, P-33 O-6 O-20, P-48, P-66 P-27, P-30 O-23 O-50 P-52

Shariati M. Sharomy H. Sheikh N. Sheikholeslami F. Shishegar F. Snourani SH. Sohan Faraji A. Soheili F. Sojudi Moghaddam MH. Solati M. Soleimani M. Soleimani Rad J. Solhjoo K. Soltani L. Soltanmorady S. Taghi Goodarzi M. Taghipor SH. Tahmoressi. Talebi A. Tavalaee M. Tavana S. Tavoosian S. Tavoosian Z. Teimoori B. Teimuri S. Toolee H. Vasegh Rahimparvar F. Vojudi E. Yaghmaei P. Yaghoubi M. Yassaee VR. Yavangi M. Yazdani MA. Yazdanpanah S. Yekta Z. Zafarani F. Zahiri M. Zahiri SH. Zandvakily F. Zavareh S. Ziaei S. Ziaie T.

O-34 O-10 O-37 P-107 P-92 P-95 P-63 P-3 P-19 P-47 P-39, P-66 O-35, P-59, P-80, P-81 P-5 P-74, P-75, P-76, P-77, P-78, P-79 O-60, P-108, P-109, P-110 O-37 P-36 P-67 P-88 O-49 P-48 P-1 P-1 P-14 P-36 O-33 O-14 P-27, P-30, P-38 O-32 P-3 P-68 O-40 P-107 P-56 O-7 P-10 P-84 O-26, P-56, P-61 P-6 P-88 O-51, O-56 O-10

Abstracts of 17th Congress of Iranian Society for Reproductive Medicine

Subscription Order Card for Iran □ I would like to receive a FREE sample copy of the Iranian Journal of Reproductive Medicine. □ Please enter my subscription to Iranian Journal of Reproductive Medicine. PERSONAL SUBSCRIPTION o Please enter my Personal Subscription for 20.000 Rials, for four issues.

STUDENT SUBSCRIPTION o Please enter my Student Subscription for 10.000 Rials for four issues. INSTITUTIONAL/LIBRARY SUBSCRIPTION o Please enter the Institutional/Library Subscription for 40.000 Rials for four issues.

ADDRESS Please print the following clearly: Name: Address: City: Phone: Email: PAYMENT METHOD o Cash o Cheque enclosed Cheque must be made to: Iranian Journal of Reproductive Medicine, Bouali Ave. Safayeh, Yazd, Iran. o Bank Transfer Transfer must be made to: Melli Bank (Aboozar Square, Code: 3517) Current Account No. Siba-2178545922005, Yazd, Iran.

Subscription Order Card for Other Countries

PERSONAL SUBSCRIPTION o Please enter my Personal Subscription for US $50 for four issues.

STUDENT SUBSCRIPTION o Please enter my Student Subscription for US $20 for four issues.

INSTITUTIONAL/LIBRARY SUBSCRIPTION o Please enter my Institutional/Library Subscription for US $100 for four issues.

ADDRESS Please print the following clearly: Name: Address: City: Phone: Email: PAYMENT METHOD o Cash o Cheque enclosed Cheque must be made to: Iranian Journal of Reproductive Medicine, Bouali Ave, Safayeh, Yazd, Iran. o Bank Transfer Transfer must be made to: Melli Bank (Aboozar Square, Code: 3517) Current Account No. Siba-2178545922005, Yazd, Iran.

Stamp

To: Iranian Journal of Reproductive Medicine, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bouali Ave, Safayeh, Yazd, Iran.

Stamp

To: Iranian Journal of Reproductive Medicine, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bouali Ave, Safayeh, Yazd, Iran.

Iranian Journal of Reproductive Medicine Send for a free sample copy today

Please send me a sample copy of the Iranian Journal of Reproductive Medicine

(IJRM).

Name: Address: Email: Iranian Journal of Reproductive Medicine, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bouali Ave, Safayeh, Yazd, Iran. [email protected]

Iranian Journal of Reproductive Medicine Send for a free sample copy today Please send me a sample copy of the Iranian Journal of Reproductive Medicine

(IJRM).

Name: Address: Email: Iranian Journal of Reproductive Medicine, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bouali Ave, Safayeh, Yazd, Iran. [email protected]

Call for Papers Iranian Journal of Reproductive Medicine (IJRM) will consider for publishing review articles, original articles, case reports and short communications in the field of reproductive medicine. If you have a manuscript that you think might be appropriate for IJRM, please submit it to our office for consideration.

Please visit our website for further details and for full Instructions for Authors http://www.ijrm.ir

Manuscript should be submitted to: Dr. Abbas Aflatoonian, Editor-in-Chief Iranian Journal of Reproductive Medicine Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Bouali Ave., Safayeh, Yazd, Iran, Postal Code: 8916877391